Innovating Global Regulatory Frameworks for Generative AI in Medical Devices
OVERVIEWA Nature commentary identifies innovating global regulatory frameworks for generative AI in medical devices as an urgent priority, arguing that current national frameworks are inadequate for the unique challenges posed by generative AI systems in clinical contexts. Unlike traditional AI/ML devices with bounded outputs, generative AI can produce novel text, images, and recommendations with unpredictable variation. The commentary calls for international regulatory coordination to prevent a fragmented landscape where generative AI medical devices face incompatible requirements across jurisdictions. Key framework gaps identified include the absence of standards for evaluating generative AI outputs for clinical safety, unclear liability allocation when generative AI produces harmful recommendations, and the lack of post-market surveillance mechanisms suited to continuously updated generative models. The urgency framing reflects the pace of generative AI deployment in healthcare: while regulatory agencies have begun issuing guidance documents and discussion papers, the gap between regulatory framework maturity and generative AI clinical deployment continues to widen. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.